Ratings by Citi (Brendan Digan)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/30/2026 | Stevanato Group S.p.A. | STVN | New Coverage | Buy (N/A) |
20.41 (20.25) |
-0.78% | Details | |
| 7/30/2026 | Sotera Health | SHC | New Coverage | Buy (N/A) |
17.53 (18.40) |
4.96% | Details | |
| 7/30/2026 | Qiagen NV | QGEN | New Coverage | Neutral (N/A) |
41.81 (42.05) |
0.57% | Details | |
| 7/30/2026 | Natera | NTRA | New Coverage | Buy (N/A) |
253.82 (323.65) |
27.51% | Details | |
| 7/30/2026 | ICON plc | ICLR | New Coverage | Neutral (N/A) |
178.18 (158.51) |
-11.04% | Details | |
| 7/30/2026 | Guardant Health | GH | New Coverage | Buy (N/A) |
144.07 (160.59) |
11.47% | Details | |
| 7/30/2026 | Fortrea | FTRE | New Coverage | Buy (N/A) |
20.40 (16.95) |
-16.91% | Details | |
| 7/30/2026 | Caris Life Sciences Inc | CAI | New Coverage | Buy (N/A) |
15.59 (24.12) |
54.71% | Details | |
| 7/30/2026 | Bruker | BRKR | New Coverage | Neutral (N/A) |
61.74 (55.79) |
-9.64% | Details | |
| 7/30/2026 | 10X Genomics | TXG | New Coverage | Neutral (N/A) |
46.32 (64.43) |
39.1% | Details |
